首页> 美国卫生研究院文献>ecancermedicalscience >A complex variant t(3;15) (q26;q13) representing cryptic/masked acute promyelocytic leukaemia with a novel breakpoint of chromosome 15—a case report
【2h】

A complex variant t(3;15) (q26;q13) representing cryptic/masked acute promyelocytic leukaemia with a novel breakpoint of chromosome 15—a case report

机译:复杂的变体t(3; 15)(q26; q13)代表具有隐匿/掩盖的急性早幼粒细胞白血病并带有新的15号染色体断裂点-病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute promyelocytic leukaemia (APML) is a biologically and clinically distinct variant of AML, currently classified as acute myeloid leukaemia with recurrent cytogenetic anomalies t(15;17) (q22;q21), promyelocytic leukaemia-retinoic acid receptor alpha, diagnosis regardless of blast count in the World Health Organization classification system. It is one of the curable malignancies, has a unique clinical presentation, often with disseminated intravascular coagulation, and has a targeted therapy for its treatment in the form of all trans retinoic acid (ATRA) and arsenic trioxide (ATO). Here, we report a complex type of variant APML t(3;15) (q26;q13), the need for conventional karyotyping for diagnosing such rare variants, and its response to ATRA and ATO.
机译:急性早幼粒细胞白血病(APML)是AML的生物学和临床独特变体,目前被分类为急性髓细胞性白血病,具有复发性细胞遗传学异常t(15; 17)(q22; q21),早幼粒细胞白血病-视黄酸受体α,无论是否爆炸都可以诊断计入世界卫生组织的分类系统。它是可治愈的恶性肿瘤之一,具有独特的临床表现,通常具有弥散性血管内凝血,并且以所有反式维甲酸(ATRA)和三氧化二砷(ATO)的形式进行靶向治疗。在这里,我们报告了一种复杂类型的APML t(3; 15)(q26; q13),需要常规核型分析来诊断此类罕见变体,以及其对ATRA和ATO的响应。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号